BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. The Lancet Neurology 2015;14:625-39. [DOI: 10.1016/s1474-4422(15)00007-1] [Cited by in Crossref: 349] [Cited by in F6Publishing: 163] [Article Influence: 49.9] [Reference Citation Analysis]
Number Citing Articles
1 Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson's disease: common pathophysiological links. Gut 2021;70:408-17. [PMID: 33067333 DOI: 10.1136/gutjnl-2020-322429] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
2 Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L, Betsou F, Krüger R, Thiele I; NCER-PD Consortium. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol 2020;18:62. [PMID: 32517799 DOI: 10.1186/s12915-020-00775-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 17.5] [Reference Citation Analysis]
3 Rosa-Grilo M, Qamar MA, Taddei RN, Pagonabarraga J, Kulisevsky J, Sauerbier A, Chaudhuri KR. Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now? NPJ Parkinsons Dis 2017;3:28. [PMID: 28890931 DOI: 10.1038/s41531-017-0030-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
4 Luthra NS, Marcus AH, Hills NK, Christine CW. Vitamin B12 measurements across neurodegenerative disorders. J Clin Mov Disord 2020;7:3. [PMID: 32257364 DOI: 10.1186/s40734-020-00085-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Erro R, Brigo F, Tamburin S, Zamboni M, Antonini A, Tinazzi M. Nutritional habits, risk, and progression of Parkinson disease. J Neurol 2018;265:12-23. [PMID: 29018983 DOI: 10.1007/s00415-017-8639-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
6 Borghammer P, Knudsen K, Fedorova TD, Brooks DJ. Imaging Parkinson's disease below the neck. NPJ Parkinsons Dis 2017;3:15. [PMID: 28649615 DOI: 10.1038/s41531-017-0017-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gries M, Christmann A, Schulte S, Weyland M, Rommel S, Martin M, Baller M, Röth R, Schmitteckert S, Unger M, Liu Y, Sommer F, Mühlhaus T, Schroda M, Timmermans JP, Pintelon I, Rappold GA, Britschgi M, Lashuel H, Menger MD, Laschke MW, Niesler B, Schäfer KH. Parkinson mice show functional and molecular changes in the gut long before motoric disease onset. Mol Neurodegener 2021;16:34. [PMID: 34078425 DOI: 10.1186/s13024-021-00439-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Bullich C, Keshavarzian A, Garssen J, Kraneveld A, Perez-Pardo P. Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis. Mov Disord Clin Pract 2019;6:639-51. [PMID: 31745471 DOI: 10.1002/mdc3.12840] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
9 Kang X, Ploner A, Roelstraete B, Khalili H, Williams DM, Pedersen NL, Ludvigsson JF, Wirdefeldt K. Association Between Microscopic Colitis and Parkinson's Disease in a Swedish Population. Mov Disord 2021;36:1919-26. [PMID: 33764622 DOI: 10.1002/mds.28594] [Reference Citation Analysis]
10 Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 2021;9:226. [PMID: 34784980 DOI: 10.1186/s40168-021-01107-9] [Reference Citation Analysis]
11 Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson's Disease. Curr Treat Options Neurol. 2018;20:54. [PMID: 30361783 DOI: 10.1007/s11940-018-0539-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
12 Zhu S, Jiang Y, Xu K, Cui M, Ye W, Zhao G, Jin L, Chen X. The progress of gut microbiome research related to brain disorders. J Neuroinflammation 2020;17:25. [PMID: 31952509 DOI: 10.1186/s12974-020-1705-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 35.5] [Reference Citation Analysis]
13 Lorente-Picón M, Laguna A. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 2021;11:433. [PMID: 33804226 DOI: 10.3390/biom11030433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Suárez Torres M, Cano Villagrasa A, Valles González B. Diagnósticos Fonoaudiológicos y Síntomas no Motores en Pacientes con Enfermedad de Parkinson. Rev Areté 2020;20:63-71. [DOI: 10.33881/1657-2513.art20207] [Reference Citation Analysis]
15 Calvani R, Picca A, Lo Monaco MR, Landi F, Bernabei R, Marzetti E. Of Microbes and Minds: A Narrative Review on the Second Brain Aging. Front Med (Lausanne) 2018;5:53. [PMID: 29552561 DOI: 10.3389/fmed.2018.00053] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
16 Perez-Pardo P, Broersen LM, Kliest T, van Wijk N, Attali A, Garssen J, Kraneveld AD. Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease. Front Aging Neurosci 2018;10:237. [PMID: 30127735 DOI: 10.3389/fnagi.2018.00237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Pellegrini C, D'Antongiovanni V, Ippolito C, Segnani C, Antonioli L, Fornai M, Bernardini N. From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease. Eur J Histochem 2021;65. [PMID: 34802221 DOI: 10.4081/ejh.2021.3278] [Reference Citation Analysis]
18 Jackson A, Forsyth CB, Shaikh M, Voigt RM, Engen PA, Ramirez V, Keshavarzian A. Diet in Parkinson's Disease: Critical Role for the Microbiome. Front Neurol 2019;10:1245. [PMID: 31920905 DOI: 10.3389/fneur.2019.01245] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
19 Heimrich KG, Jacob VYP, Schaller D, Stallmach A, Witte OW, Prell T. Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells. NPJ Parkinsons Dis 2019;5:15. [PMID: 31372495 DOI: 10.1038/s41531-019-0087-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
20 Desmet AS, Cirillo C, Tack J, Vandenberghe W, Vanden Berghe P. Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls. Elife 2017;6:e26850. [PMID: 28825895 DOI: 10.7554/eLife.26850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
21 van Kessel SP, de Jong HR, Winkel SL, van Leeuwen SS, Nelemans SA, Permentier H, Keshavarzian A, El Aidy S. Gut bacterial deamination of residual levodopa medication for Parkinson's disease. BMC Biol 2020;18:137. [PMID: 33076930 DOI: 10.1186/s12915-020-00876-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Reza MM, Finlay BB, Pettersson S. Gut microbes, ageing & organ function: a chameleon in modern biology? EMBO Mol Med 2019;11:e9872. [PMID: 31410991 DOI: 10.15252/emmm.201809872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Hertel J, Harms AC, Heinken A, Baldini F, Thinnes CC, Glaab E, Vasco DA, Trenkwalder C, Krüger R, Hankemeier T, Fleming RMT, Mollenhauer B, Thiele I. Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease. SSRN Journal. [DOI: 10.2139/ssrn.3305554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 van Kessel SP, Auvinen P, Scheperjans F, El Aidy S. Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease. NPJ Parkinsons Dis 2021;7:115. [PMID: 34911958 DOI: 10.1038/s41531-021-00260-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Cox LM, Weiner HL. Microbiota Signaling Pathways that Influence Neurologic Disease. Neurotherapeutics 2018;15:135-45. [PMID: 29340928 DOI: 10.1007/s13311-017-0598-8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 18.7] [Reference Citation Analysis]
26 Linard M, Ravier A, Mougué L, Grgurina I, Boutillier AL, Foubert-Samier A, Blanc F, Helmer C. Infectious Agents as Potential Drivers of α-Synucleinopathies. Mov Disord 2022. [PMID: 35040520 DOI: 10.1002/mds.28925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Su A, Gandhy R, Barlow C, Triadafilopoulos G. Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms. BMJ Open Gastroenterol 2017;4:e000132. [PMID: 28321329 DOI: 10.1136/bmjgast-2017-000132] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
28 Garcia-Casado J, Prats-Boluda G, Ye-Lin Y, Restrepo-Agudelo S, Perez-Giraldo E, Orozco-Duque A. Evaluation of Swallowing Related Muscle Activity by Means of Concentric Ring Electrodes. Sensors (Basel) 2020;20:E5267. [PMID: 32942616 DOI: 10.3390/s20185267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Pedrosa Carrasco AJ, Timmermann L, Pedrosa DJ. Management of constipation in patients with Parkinson's disease. NPJ Parkinsons Dis 2018;4:6. [PMID: 29560414 DOI: 10.1038/s41531-018-0042-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
30 Blum HE. The human microbiome. Adv Med Sci 2017;62:414-20. [PMID: 28711782 DOI: 10.1016/j.advms.2017.04.005] [Cited by in Crossref: 100] [Cited by in F6Publishing: 73] [Article Influence: 20.0] [Reference Citation Analysis]
31 Fleury V, Zekeridou A, Lazarevic V, Gaïa N, Giannopoulou C, Genton L, Cancela J, Girard M, Goldstein R, Bally JF, Mombelli A, Schrenzel J, Burkhard PR. Oral Dysbiosis and Inflammation in Parkinson's Disease. J Parkinsons Dis 2021;11:619-31. [PMID: 33646178 DOI: 10.3233/JPD-202459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Levine TD, Bellaire B, Gibbons C, Freeman R. Cutaneous alpha-synuclein deposition in postural tachycardia patients. Ann Clin Transl Neurol 2021;8:908-17. [PMID: 33764697 DOI: 10.1002/acn3.51347] [Reference Citation Analysis]
33 Dhar S, Singh J, Singh P. Insights into various dysfunctions in Parkinson’s disease: a survey. CSIT 2016;4:117-22. [DOI: 10.1007/s40012-016-0127-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Nazeen S, Yu YW, Berger B. Carnelian uncovers hidden functional patterns across diverse study populations from whole metagenome sequencing reads. Genome Biol 2020;21:47. [PMID: 32093762 DOI: 10.1186/s13059-020-1933-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
35 Horsager J, Knudsen K, Sommerauer M. Clinical and imaging evidence of brain-first and body-first Parkinson's disease. Neurobiol Dis 2022;:105626. [PMID: 35031485 DOI: 10.1016/j.nbd.2022.105626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
36 Stuart BAR, Franitza AL, E L. Regulatory Roles of Antimicrobial Peptides in the Nervous System: Implications for Neuronal Aging. Front Cell Neurosci 2022;16:843790. [DOI: 10.3389/fncel.2022.843790] [Reference Citation Analysis]
37 Antunes I, Purim KSM, Grande LL, Alberton NC, Navarro TFR, Winckler TCD. Dermatoses in parkinsonism: the importance of multidisciplinary follow-up. Rev Assoc Med Bras 2019;65:791-5. [DOI: 10.1590/1806-9282.65.6.791] [Reference Citation Analysis]
38 Martin CR, Mayer EA. Gut-Brain Axis and Behavior. Nestle Nutr Inst Workshop Ser 2017;88:45-53. [PMID: 28346923 DOI: 10.1159/000461732] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
39 Miyazaki I, Asanuma M. Neuron-Astrocyte Interactions in Parkinson's Disease. Cells 2020;9:E2623. [PMID: 33297340 DOI: 10.3390/cells9122623] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
40 Verugina NI, Levin OS, Lyashenko EA. [The role of the gut microbiota in Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:86-91. [PMID: 34870920 DOI: 10.17116/jnevro202112110286] [Reference Citation Analysis]
41 Anselmi L, Toti L, Bove C, Hampton J, Travagli RA. A Nigro-Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism. Gastroenterology 2017;153:1581-93. [PMID: 28912019 DOI: 10.1053/j.gastro.2017.08.069] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
42 Khoshbin K, Hassan A, Camilleri M. Cohort Study in Parkinsonism: Delayed Transit, Accelerated Gastric Emptying, and Prodromal Dysmotility. Neurol Clin Pract 2021;11:e407-13. [PMID: 34484938 DOI: 10.1212/CPJ.0000000000001003] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Luan M, Jin J, Wang Y, Li X, Xiea A. Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population. Neurosci Lett 2022;:136547. [PMID: 35218888 DOI: 10.1016/j.neulet.2022.136547] [Reference Citation Analysis]
44 Dijk JM, Espay AJ, Katzenschlager R, de Bie RMA. The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When? J Parkinsons Dis 2020;10:S65-73. [PMID: 32651333 DOI: 10.3233/JPD-202104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
45 Hinkle JT, Perepezko K, Mills KA, Mari Z, Butala A, Dawson TM, Pantelyat A, Rosenthal LS, Pontone GM. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease. Parkinsonism Relat Disord 2018;55:8-14. [PMID: 30146185 DOI: 10.1016/j.parkreldis.2018.08.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
46 Han MN, Finkelstein DI, Mcquade RM, Diwakarla S. Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics. JPM 2022;12:144. [DOI: 10.3390/jpm12020144] [Reference Citation Analysis]
47 Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Reference Citation Analysis]
48 Pellegrini C, D'Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, Cattaneo A, Blandizzi C, Colla E, Fornai M. Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology. NPJ Parkinsons Dis 2022;8:9. [PMID: 35022395 DOI: 10.1038/s41531-021-00263-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ivan IF, Irincu VL, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Falup-Pecurariu C. Gastro-intestinal dysfunctions in Parkinson's disease (Review). Exp Ther Med 2021;22:1083. [PMID: 34447476 DOI: 10.3892/etm.2021.10517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Frazzitta G, Ferrazzoli D, Folini A, Palamara G, Maestri R. Severe Constipation in Parkinson's Disease and in Parkinsonisms: Prevalence and Affecting Factors. Front Neurol 2019;10:621. [PMID: 31275225 DOI: 10.3389/fneur.2019.00621] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
51 Cosma-Grigorov A, Meixner H, Mrochen A, Wirtz S, Winkler J, Marxreiter F. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates. Front Neurol 2020;11:1041. [PMID: 33071933 DOI: 10.3389/fneur.2020.01041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wüllner U. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients. Genome Med 2017;9:39. [PMID: 28449715 DOI: 10.1186/s13073-017-0428-y] [Cited by in Crossref: 192] [Cited by in F6Publishing: 194] [Article Influence: 38.4] [Reference Citation Analysis]
53 Miyazaki I, Isooka N, Imafuku F, Sun J, Kikuoka R, Furukawa C, Asanuma M. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease. Int J Mol Sci 2020;21:E3254. [PMID: 32375371 DOI: 10.3390/ijms21093254] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
54 Kornum DS, Terkelsen AJ, Bertoli D, Klinge MW, Høyer KL, Kufaishi HHA, Borghammer P, Drewes AM, Brock C, Krogh K. Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives. J Clin Med 2021;10:1392. [PMID: 33807256 DOI: 10.3390/jcm10071392] [Reference Citation Analysis]
55 Magistrelli L, Amoruso A, Mogna L, Graziano T, Cantello R, Pane M, Comi C. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence. Front Immunol 2019;10:969. [PMID: 31134068 DOI: 10.3389/fimmu.2019.00969] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
56 Bove C, Coleman FH, Travagli RA. Characterization of the Basic Membrane Properties of Neurons of the Rat Dorsal Motor Nucleus of the Vagus in Paraquat-Induced Models of Parkinsonism. Neuroscience 2019;418:122-32. [PMID: 31491501 DOI: 10.1016/j.neuroscience.2019.08.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
57 Muhle P, Claus I, Labeit B, Ogawa M, Dziewas R, Suntrup-Krueger S, Warnecke T. Effects of cognitive and motor dual-tasks on oropharyngeal swallowing assessed with FEES in healthy individuals. Sci Rep 2020;10:20403. [PMID: 33230259 DOI: 10.1038/s41598-020-77421-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Fattori B, Nacci A, Farneti D, Ceravolo R, Santoro A, Bastiani L, Simoni F, Pagani R, De Bortoli N. Dysphagia in Parkinson's disease: Pharyngeal manometry and fiberoptic endoscopic evaluation. Auris Nasus Larynx 2022. [DOI: 10.1016/j.anl.2022.03.016] [Reference Citation Analysis]
59 Siebner TH, Fuglsang S, Madelung CF, Løkkegaard A, Bendtsen F, Hove JD, Damgaard M, Madsen JL, Siebner HR. Gastric Emptying Is Not Delayed and Does Not Correlate With Attenuated Postprandial Blood Flow Increase in Medicated Patients With Early Parkinson's Disease. Front Neurol 2022;13:828069. [DOI: 10.3389/fneur.2022.828069] [Reference Citation Analysis]
60 Parker-Character J, Hager DR, Call TB, Pickup ZS, Turnbull SA, Marshman EM, Korch SB, Chaston JM, Call GB. An altered microbiome in a Parkinson's disease model Drosophila melanogaster has a negative effect on development. Sci Rep 2021;11:23635. [PMID: 34880269 DOI: 10.1038/s41598-021-02624-1] [Reference Citation Analysis]
61 Bayoumi Y, Sobhy N, Morsi A, El-Neshwey W, El-Seddawy N, Abdallah A. Clinical and histopathological studies on neurodegeneration and dysautonomia in buffalo calves during foot-and-mouth disease outbreaks in Egypt. Vet World 2021;14:1622-30. [PMID: 34316212 DOI: 10.14202/vetworld.2021.1622-1630] [Reference Citation Analysis]
62 Parrella E, Bellucci A, Porrini V, Benarese M, Lanzillotta A, Faustini G, Longhena F, Abate G, Uberti D, Pizzi M. NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice. Transl Neurodegener 2019;8:16. [PMID: 31139367 DOI: 10.1186/s40035-019-0154-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
63 Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP. Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation. J Neurogastroenterol Motil 2019;25:363-76. [PMID: 31327219 DOI: 10.5056/jnm19044] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 21.0] [Reference Citation Analysis]
64 Fu P, Gao M, Yung KKL. Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis. ACS Chem Neurosci 2020;11:395-405. [PMID: 31876406 DOI: 10.1021/acschemneuro.9b00607] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 17.5] [Reference Citation Analysis]
65 Yu X, Jiang HY, Zhang CX, Jin ZH, Gao L, Wang RD, Fang JP, Su Y, Xi JN, Fang BY. The Role of the Diaphragm in Postural Stability and Visceral Function in Parkinson's Disease. Front Aging Neurosci 2021;13:785020. [PMID: 35002681 DOI: 10.3389/fnagi.2021.785020] [Reference Citation Analysis]
66 Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Fukae J, Nakamura R, Kurita N, Tsunemi T, Oji Y, Saiki S, Nishioka K, Takeshige-Amano H, Taniguchi D, Ogawa T, Kamo H, Eguchi H, Fuse A, Nakajima A, Kano M, Nakajima S, Yanagisawa N, Hattori N. Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD). BMJ Open 2022;12:e054129. [PMID: 35149566 DOI: 10.1136/bmjopen-2021-054129] [Reference Citation Analysis]
67 Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota-gut-brain axis. Acta Pharm Sin B 2021;11:2859-79. [PMID: 34589401 DOI: 10.1016/j.apsb.2021.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Guebila MB, Thiele I. Model-based dietary optimization for late-stage, levodopa-treated, Parkinson's disease patients. NPJ Syst Biol Appl 2016;2:16013. [PMID: 28725472 DOI: 10.1038/npjsba.2016.13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
69 Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020;17:673-85. [PMID: 32737460 DOI: 10.1038/s41575-020-0339-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 23.5] [Reference Citation Analysis]
70 Perez-Pardo P, Hartog M, Garssen J, Kraneveld AD. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease. Curr Behav Neurosci Rep 2017;4:361-8. [PMID: 29201595 DOI: 10.1007/s40473-017-0129-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
71 Knudsen K, Borghammer P. Imaging the Autonomic Nervous System in Parkinson's Disease. Curr Neurol Neurosci Rep 2018;18:79. [PMID: 30232650 DOI: 10.1007/s11910-018-0889-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
72 Caputi V, Giron MC. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease. Int J Mol Sci. 2018;19. [PMID: 29882798 DOI: 10.3390/ijms19061689] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 26.8] [Reference Citation Analysis]
73 Perez-Pardo P, de Jong EM, Broersen LM, van Wijk N, Attali A, Garssen J, Kraneveld AD. Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease. Front Aging Neurosci 2017;9:57. [PMID: 28373840 DOI: 10.3389/fnagi.2017.00057] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
74 Niesler B, Kuerten S, Demir IE, Schäfer KH. Disorders of the enteric nervous system - a holistic view. Nat Rev Gastroenterol Hepatol 2021;18:393-410. [PMID: 33514916 DOI: 10.1038/s41575-020-00385-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 28.0] [Reference Citation Analysis]
75 Camacho M, Macleod AD, Maple-Grødem J, Evans JR, Breen DP, Cummins G, Wijeyekoon RS, Greenland JC, Alves G, Tysnes OB, Lawson RA, Barker RA, Williams-Gray CH. Early constipation predicts faster dementia onset in Parkinson's disease. NPJ Parkinsons Dis 2021;7:45. [PMID: 34039994 DOI: 10.1038/s41531-021-00191-w] [Reference Citation Analysis]
76 Bove C, Travagli RA. Neurophysiology of the brain stem in Parkinson's disease. J Neurophysiol 2019;121:1856-64. [PMID: 30917059 DOI: 10.1152/jn.00056.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
77 Shultz JM, Resnikoff H, Bondarenko V, Joers V, Mejia A, Simmons H, Emborg ME. Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys. J Alzheimers Dis Parkinsonism 2016;6:279. [PMID: 28090391 DOI: 10.4172/2161-0460.1000279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
78 Liu Y, Niu L, Liu X, Cheng C, Le W. Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation. Neurosci Bull 2021;37:1010-24. [PMID: 34128188 DOI: 10.1007/s12264-021-00711-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Anselmi L, Bove C, Coleman FH, Le K, Subramanian MP, Venkiteswaran K, Subramanian T, Travagli RA. Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat. NPJ Parkinsons Dis 2018;4:30. [PMID: 30302391 DOI: 10.1038/s41531-018-0066-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
80 Boursi B, Mamtani R, Haynes K, Yang YX. Parkinson's disease and colorectal cancer risk-A nested case control study. Cancer Epidemiol 2016;43:9-14. [PMID: 27232063 DOI: 10.1016/j.canep.2016.05.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
81 Yakabi K, Yamaguchi N, Ono S, Yoshida N, Hosomi E, Hayashi K, Ochiai M, Maezawa K, Nomura K. Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study. Curr Ther Res Clin Exp 2017;87:1-8. [PMID: 28912900 DOI: 10.1016/j.curtheres.2017.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
82 Miyazaki I, Asanuma M. The Rotenone Models Reproducing Central and Peripheral Features of Parkinson’s Disease. NeuroSci 2020;1:1-14. [DOI: 10.3390/neurosci1010001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Reference Citation Analysis]
84 Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, MacDougall G, Dunlop SA, Mastaglia FL, Akkari PA, Koengten F, Anderton RS. Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model. Front Neurosci 2019;13:839. [PMID: 31440136 DOI: 10.3389/fnins.2019.00839] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 16.0] [Reference Citation Analysis]
85 Wang C, Zheng C. Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions. Front Pharmacol 2022;13:875349. [DOI: 10.3389/fphar.2022.875349] [Reference Citation Analysis]
86 Edwards Iii G, Gamez N, Armijo E, Kramm C, Morales R, Taylor-Presse K, Schulz PE, Soto C, Moreno-Gonzalez I. Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson's Disease-Associated Pathology. Cells 2019;8:E1359. [PMID: 31671704 DOI: 10.3390/cells8111359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
87 Chandramowlishwaran P, Vijay A, Abraham D, Li G, Mwangi SM, Srinivasan S. Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System. Front Neurosci 2020;14:614331. [PMID: 33414704 DOI: 10.3389/fnins.2020.614331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
88 Amara AW, Memon AA. Effects of Exercise on Non-motor Symptoms in Parkinson's Disease. Clin Ther 2018;40:8-15. [PMID: 29198450 DOI: 10.1016/j.clinthera.2017.11.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 7.4] [Reference Citation Analysis]
89 Lee HJ, Jung KW, Chung SJ, Hong SM, Kim J, Lee JH, Hwang SW, Ryu HS, Kim MJ, Lee HS, Seo M, Park SH, Yang DH, Ye BD, Byeon JS, Choe J, Jung HY, Yang SK, Myung SJ. Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects. J Neurogastroenterol Motil 2018;24:469-78. [PMID: 29969861 DOI: 10.5056/jnm17141] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
90 Binks S, Dobson R. Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease. Curr Osteoporos Rep 2016;14:199-210. [PMID: 27525980 DOI: 10.1007/s11914-016-0320-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
91 Bove C, Anselmi L, Travagli RA. Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism. Am J Physiol Gastrointest Liver Physiol 2019;317:G1-7. [PMID: 31042398 DOI: 10.1152/ajpgi.00076.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
92 Ruck L, Unger MM, Spiegel J, Bürmann J, Dillmann U, Faßbender K, Reith W, Backens M, Mühl-Benninghaus R, Yilmaz U. Gastric Motility in Parkinson's Disease is Altered Depending on the Digestive Phase and Does Not Correlate with Patient-Reported Motor Fluctuations. J Parkinsons Dis 2020;10:1699-707. [PMID: 32804102 DOI: 10.3233/JPD-202144] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Yang C, Qiu Y, Qing Y, Xu J, Dai W, Hu X, Wu X. Synergistic effect of electric stimulation and mesenchymal stem cells against Parkinson's disease. Aging (Albany NY) 2020;12:16062-71. [PMID: 32836217 DOI: 10.18632/aging.103477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Masala C, Loy F, Piras R, Liscia A, Fadda L, Moat A, Solla P, Defazio G. Effect of Olfactory and Gustatory Dysfunction and Motor Symptoms on Body Weight in Patients with Parkinson's Disease. Brain Sci 2020;10:E218. [PMID: 32272584 DOI: 10.3390/brainsci10040218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
95 Nouraei N, Mason DM, Miner KM, Carcella MA, Bhatia TN, Dumm BK, Soni D, Johnson DA, Luk KC, Leak RK. Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders. Exp Neurol 2018;299:172-96. [PMID: 29056362 DOI: 10.1016/j.expneurol.2017.10.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
96 Giancola F, Torresan F, Repossi R, Bianco F, Latorre R, Ioannou A, Guarino M, Volta U, Clavenzani P, Mazzoni M, Chiocchetti R, Bazzoli F, Travagli RA, Sternini C, De Giorgio R. Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation. Neurogastroenterol Motil 2017;29. [PMID: 27891695 DOI: 10.1111/nmo.12995] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
97 Mishima T, Fukae J, Fujioka S, Inoue K, Tsuboi Y. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria. J Parkinsons Dis 2017;7:353-7. [PMID: 28157108 DOI: 10.3233/JPD-160982] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
98 Putra RD, Lyrawati D. Interactions between Bacteriophages and Eukaryotic Cells. Scientifica (Cairo) 2020;2020:3589316. [PMID: 32582449 DOI: 10.1155/2020/3589316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Nuzum ND, Loughman A, Szymlek-Gay EA, Teo WP, Hendy AM, Macpherson H. To the Gut Microbiome and Beyond: The Brain-First or Body-First Hypothesis in Parkinson's Disease. Front Microbiol 2022;13:791213. [PMID: 35432226 DOI: 10.3389/fmicb.2022.791213] [Reference Citation Analysis]
100 Olubodun-Obadun TG, Ishola IO, Adeyemi OO. Impact of environmental toxicants exposure on gut-brain axis in Parkinson disease. Drug Metab Pers Ther 2022. [PMID: 35377569 DOI: 10.1515/dmpt-2021-0144] [Reference Citation Analysis]
101 Choi JH, Lee JY, Cho JW, Koh SB, Yang YS, Yoo D, Shin CM, Kim HT. Double-Blind, Randomized, Placebo-Controlled Trial of DA-9701 in Parkinson's Disease: PASS-GI Study. Mov Disord 2020;35:1966-76. [PMID: 32761955 DOI: 10.1002/mds.28219] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Zapanta K, Schroeder ET, Fisher BE. Rethinking Parkinson Disease: Exploring Gut-Brain Interactions and the Potential Role of Exercise. Phys Ther 2022;102:pzac022. [PMID: 35225349 DOI: 10.1093/ptj/pzac022] [Reference Citation Analysis]
103 Farrow SL, Cooper AA, O'Sullivan JM. Redefining the hypotheses driving Parkinson's diseases research. NPJ Parkinsons Dis 2022;8:45. [PMID: 35440633 DOI: 10.1038/s41531-022-00307-w] [Reference Citation Analysis]
104 Zheng J, Wang M, Wei W, Keller JN, Adhikari B, King JF, King ML, Peng N, Laine RA. Dietary Plant Lectins Appear to Be Transported from the Gut to Gain Access to and Alter Dopaminergic Neurons of Caenorhabditis elegans, a Potential Etiology of Parkinson's Disease. Front Nutr 2016;3:7. [PMID: 27014695 DOI: 10.3389/fnut.2016.00007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
105 Singh Y, El-Hadidi M, Admard J, Wassouf Z, Schulze-Hentrich JM, Kohlhofer U, Quintanilla-Martinez L, Huson D, Riess O, Casadei N. Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson's Disease. Front Neurosci 2019;13:1032. [PMID: 31749671 DOI: 10.3389/fnins.2019.01032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
106 Yokoi K, Hattori M, Satake Y, Tanaka Y, Sato M, Hashizume A, Hori A, Kawashima M, Hirakawa A, Watanabe H, Katsuno M. Longitudinal analysis of premotor anthropometric and serological markers of Parkinson's disease. Sci Rep 2020;10:20524. [PMID: 33239649 DOI: 10.1038/s41598-020-77415-1] [Reference Citation Analysis]
107 Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 2017;20:145-55. [PMID: 28092661 DOI: 10.1038/nn.4476] [Cited by in Crossref: 646] [Cited by in F6Publishing: 596] [Article Influence: 129.2] [Reference Citation Analysis]
108 Poirier A, Côté M, Jarras H, Litim N, Lamontagne-proulx J, Al-sweidi S, Morissette M, Lachhab A, Pelletier M, Di Paolo T, Soulet D. Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models. Front Pharmacol 2022;13:898067. [DOI: 10.3389/fphar.2022.898067] [Reference Citation Analysis]
109 Suttrup I, Warnecke T. Dysphagia in Parkinson's Disease. Dysphagia 2016;31:24-32. [PMID: 26590572 DOI: 10.1007/s00455-015-9671-9] [Cited by in Crossref: 159] [Cited by in F6Publishing: 121] [Article Influence: 22.7] [Reference Citation Analysis]
110 Zhang X, Shao Z, Xu S, Liu Q, Liu C, Luo Y, Jin L, Li S. Immune Profiling of Parkinson's Disease Revealed Its Association With a Subset of Infiltrating Cells and Signature Genes. Front Aging Neurosci 2021;13:605970. [PMID: 33633562 DOI: 10.3389/fnagi.2021.605970] [Reference Citation Analysis]
111 Allan LM. Diagnosis and Management of Autonomic Dysfunction in Dementia Syndromes. Curr Treat Options Neurol 2019;21:38. [PMID: 31290049 DOI: 10.1007/s11940-019-0581-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
112 Khedr EM, Ali AM, Deaf E, Hassan HM, Alaa A, Gamea A. Gut microbiota in Parkinson’s disease patients: hospital-based study. Egypt J Neurol Psychiatry Neurosurg 2021;57. [DOI: 10.1186/s41983-021-00407-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Soliman H, Coffin B, Gourcerol G. Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management. Brain Sci 2021;11:831. [PMID: 34201699 DOI: 10.3390/brainsci11070831] [Reference Citation Analysis]
114 Fagerberg P, Klingelhoefer L, Bottai M, Langlet B, Kyritsis K, Rotter E, Reichmann H, Falkenburger B, Delopoulos A, Ioakimidis I. Lower Energy Intake among Advanced vs. Early Parkinson's Disease Patients and Healthy Controls in a Clinical Lunch Setting: A Cross-Sectional Study. Nutrients 2020;12:E2109. [PMID: 32708668 DOI: 10.3390/nu12072109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
115 Barrenschee M, Zorenkov D, Böttner M, Lange C, Cossais F, Scharf AB, Deuschl G, Schneider SA, Ellrichmann M, Fritscher-Ravens A, Wedel T. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease. Acta Neuropathol Commun 2017;5:1. [PMID: 28057070 DOI: 10.1186/s40478-016-0408-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
116 LeWitt PA, Pahwa R, Sedkov A, Corbin A, Batycky R, Murck H. Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease. J Aerosol Med Pulm Drug Deliv 2018;31:155-61. [PMID: 29161531 DOI: 10.1089/jamp.2016.1354] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
117 Fan HX, Sheng S, Zhang F. New hope for Parkinson's disease treatment: Targeting gut microbiota. CNS Neurosci Ther 2022. [PMID: 35822696 DOI: 10.1111/cns.13916] [Reference Citation Analysis]
118 Ogawa T, Oyama G, Hattori N. Transdermal rotigotine patch in Parkinson's disease with a history of intestinal operation. BMJ Case Rep 2018;2018:bcr-2017-223722. [PMID: 29909386 DOI: 10.1136/bcr-2017-223722] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
119 Chen Y, Fang L, Chen S, Zhou H, Fan Y, Lin L, Li J, Xu J, Chen Y, Ma Y, Chen Y. Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease. Biomed Res Int 2020;2020:8456596. [PMID: 32596386 DOI: 10.1155/2020/8456596] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
120 Wang J, Yang X, Zeng W, Zhang X, Yang X, Xu Y, Liu K, Zhang Z, Xu Y, Cao X. Dual Effects: Intrastriatal Injection of α-syn N103/tau N368 Preformed Fibrils Promotes Endogenous α-synuclein Aggregates in the Proximal Colon. J Parkinsons Dis 2022. [PMID: 35912751 DOI: 10.3233/JPD-223294] [Reference Citation Analysis]
121 Deng I, Corrigan F, Zhai G, Zhou XF, Bobrovskaya L. Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease. Brain Behav Immun Health 2020;4:100060. [PMID: 34589845 DOI: 10.1016/j.bbih.2020.100060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
122 Fang P, Kazmi SA, Jameson KG, Hsiao EY. The Microbiome as a Modifier of Neurodegenerative Disease Risk. Cell Host Microbe 2020;28:201-22. [PMID: 32791113 DOI: 10.1016/j.chom.2020.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
123 Memic F, Knoflach V, Sadler R, Tegerstedt G, Sundström E, Guillemot F, Pachnis V, Marklund U. Ascl1 Is Required for the Development of Specific Neuronal Subtypes in the Enteric Nervous System. J Neurosci 2016;36:4339-50. [PMID: 27076429 DOI: 10.1523/JNEUROSCI.0202-16.2016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
124 Bohlin J, Dahlin E, Dreja J, Roth B, Ekberg O, Ohlsson B. Longer colonic transit time is associated with laxative and drug use, lifestyle factors, and symptoms of constipation. Acta Radiol Open 2018;7:2058460118807232. [PMID: 30364803 DOI: 10.1177/2058460118807232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
125 Ma K, Xiong N, Shen Y, Han C, Liu L, Zhang G, Wang L, Guo S, Guo X, Xia Y, Wan F, Huang J, Lin Z, Wang T. Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects. Front Aging Neurosci 2018;10:1. [PMID: 29403371 DOI: 10.3389/fnagi.2018.00001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 11.8] [Reference Citation Analysis]
126 Nascimento D. Clinical features associated with drooling in Parkinson's disease. Neurol Sci 2021;42:895-903. [PMID: 33443673 DOI: 10.1007/s10072-020-05005-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci 2017;18:435-50. [PMID: 28592904 DOI: 10.1038/nrn.2017.62] [Cited by in Crossref: 429] [Cited by in F6Publishing: 407] [Article Influence: 85.8] [Reference Citation Analysis]
128 Metzger JM, Emborg ME. Autonomic dysfunction in Parkinson disease and animal models. Clin Auton Res 2019;29:397-414. [PMID: 30604165 DOI: 10.1007/s10286-018-00584-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
129 Tan AH, Lim SY, Lang AE. The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic. Nat Rev Neurol 2022. [PMID: 35750883 DOI: 10.1038/s41582-022-00681-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Pizarro N, Kossatz E, González P, Gamero A, Veza E, Fernández C, Gabaldón T, de la Torre R, Robledo P. Sex-Specific Effects of Synbiotic Exposure in Mice on Addictive-Like Behavioral Alterations Induced by Chronic Alcohol Intake Are Associated With Changes in Specific Gut Bacterial Taxa and Brain Tryptophan Metabolism. Front Nutr 2021;8:750333. [PMID: 34901109 DOI: 10.3389/fnut.2021.750333] [Reference Citation Analysis]
131 Mao CJ, Xiong YT, Wang F, Yang YP, Yuan W, Zhu C, Chen J, Liu CF. Motor subtypes and other risk factors associated with drooling in Parkinson's disease patients. Acta Neurol Scand 2018;137:509-14. [PMID: 29315470 DOI: 10.1111/ane.12893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
132 Chung KA, Pfeiffer RF. Gastrointestinal dysfunction in the synucleinopathies. Clin Auton Res 2021;31:77-99. [PMID: 33247399 DOI: 10.1007/s10286-020-00745-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
133 Cabanillas-Lazo M, Quispe-Vicuña C, Barja-Ore J, Fernandez-Giusti A, Munive-Degregori A, Retamozo-Siancas Y, Guerrero ME, Mayta-Tovalino F. A 10-Year Bibliometric Analysis of Global Research on Gut Microbiota and Parkinson's Disease: Characteristics, Impact, and Trends. Biomed Res Int 2022;2022:4144781. [PMID: 35795315 DOI: 10.1155/2022/4144781] [Reference Citation Analysis]
134 Henderson MX, Trojanowski JQ, Lee VM. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies. Neurosci Lett 2019;709:134316. [PMID: 31170426 DOI: 10.1016/j.neulet.2019.134316] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 18.7] [Reference Citation Analysis]
135 Pisa D, Alonso R, Carrasco L. Parkinson's Disease: A Comprehensive Analysis of Fungi and Bacteria in Brain Tissue. Int J Biol Sci 2020;16:1135-52. [PMID: 32174790 DOI: 10.7150/ijbs.42257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
136 Simchovitz A, Heneka MT, Soreq H. Personalized genetics of the cholinergic blockade of neuroinflammation. J Neurochem 2017;142 Suppl 2:178-87. [PMID: 28326544 DOI: 10.1111/jnc.13928] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
137 Mackinnon RE. The complications of jejunostomy tubes for patients receiving Duodopa: New challenges for neuroscience nurses. Australasian Journal of Neuroscience 2017;27:1-4. [DOI: 10.21307/ajon-2017-001] [Reference Citation Analysis]
138 James DM, Davidson EA, Yanes J, Moshiree B, Dallman JE. The Gut-Brain-Microbiome Axis and Its Link to Autism: Emerging Insights and the Potential of Zebrafish Models. Front Cell Dev Biol 2021;9:662916. [PMID: 33937265 DOI: 10.3389/fcell.2021.662916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Chiang HL, Lin CH. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease. J Mov Disord 2019;12:67-83. [PMID: 31158941 DOI: 10.14802/jmd.18067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
140 McClurg D, Hagen S, Jamieson K, Dickinson L, Paul L, Cunnington A. Abdominal massage for the alleviation of symptoms of constipation in people with Parkinson's: a randomised controlled pilot study. Age Ageing 2016;45:299-303. [PMID: 26826459 DOI: 10.1093/ageing/afw005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
141 Sampath C, Kalpana R, Ansah T, Charlton C, Hale A, Channon KM, Srinivasan S, Gangula PR. Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease. Dig Dis Sci 2019;64:3502-17. [PMID: 31187328 DOI: 10.1007/s10620-019-05693-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
142 Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, Palotás A. Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease. J Nutr Biochem 2018;61:1-16. [PMID: 29886183 DOI: 10.1016/j.jnutbio.2018.04.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
143 Ghyselinck J, Verstrepen L, Moens F, Van Den Abbeele P, Bruggeman A, Said J, Smith B, Barker LA, Jordan C, Leta V, Chaudhuri KR, Basit AW, Gaisford S. Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease. Int J Pharm X 2021;3:100087. [PMID: 34977556 DOI: 10.1016/j.ijpx.2021.100087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
144 Siebner TH, Fugl Madelung C, Bendtsen F, Løkkegaard A, Hove JD, Siebner HR. Postprandial Increase in Mesenteric Blood Flow is Attenuated in Parkinson's Disease: A Dynamic PC-MRI Study. J Parkinsons Dis 2021;11:545-57. [PMID: 33427695 DOI: 10.3233/JPD-202341] [Reference Citation Analysis]
145 Warnecke T, Schäfer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis 2022;8:31. [PMID: 35332158 DOI: 10.1038/s41531-022-00295-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
146 Tomita S, Oeda T, Umemura A, Kohsaka M, Park K, Yamamoto K, Sugiyama H, Sawada H. Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson's disease. PLoS One 2018;13:e0197608. [PMID: 29874285 DOI: 10.1371/journal.pone.0197608] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
147 Fang X. Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis. Metab Brain Dis 2018;33:1031-43. [PMID: 29681010 DOI: 10.1007/s11011-018-0239-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
148 Gan J, Wan Y, Shi J, Zhou M, Lou Z, Liu Z. A survey of subjective constipation in Parkinson's disease patients in shanghai and literature review. BMC Neurol 2018;18:29. [PMID: 29544459 DOI: 10.1186/s12883-018-1034-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
149 Mertsalmi TH, But A, Pekkonen E, Scheperjans F. Irritable Bowel Syndrome and Risk of Parkinson's Disease in Finland: A Nationwide Registry-Based Cohort Study. J Parkinsons Dis 2021;11:641-51. [PMID: 33646176 DOI: 10.3233/JPD-202330] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
150 Vascellari S, Palmas V, Melis M, Pisanu S, Cusano R, Uva P, Perra D, Madau V, Sarchioto M, Oppo V, Simola N, Morelli M, Santoru ML, Atzori L, Melis M, Cossu G, Manzin A. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease. mSystems 2020;5:e00561-20. [PMID: 32934117 DOI: 10.1128/mSystems.00561-20] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
151 Serra MC, Landry A, Juncos JL, Markland AD, Burgio KL, Goode PS, Johnson TM 2nd, Vaughan CP. Increased odds of bladder and bowel symptoms in early Parkinson's disease. Neurourol Urodyn 2018;37:1344-8. [PMID: 29095515 DOI: 10.1002/nau.23443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
152 Miranda-Ribera A, Serena G, Liu J, Fasano A, Kingsbury MA, Fiorentino MR. The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota. Tissue Barriers 2021;:2000299. [PMID: 34775911 DOI: 10.1080/21688370.2021.2000299] [Reference Citation Analysis]
153 Miyazaki I, Isooka N, Wada K, Kikuoka R, Kitamura Y, Asanuma M. Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice. Cells 2019;8:E221. [PMID: 30866481 DOI: 10.3390/cells8030221] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
154 Yang X, Qian Y, Xu S, Song Y, Xiao Q. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease. Front Aging Neurosci 2017;9:441. [PMID: 29358918 DOI: 10.3389/fnagi.2017.00441] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
155 de la Fuente-Nunez C, Meneguetti BT, Franco OL, Lu TK. Neuromicrobiology: How Microbes Influence the Brain. ACS Chem Neurosci 2018;9:141-50. [PMID: 29220570 DOI: 10.1021/acschemneuro.7b00373] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
156 Su A, Gandhy R, Barlow C, Triadafilopoulos G. Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson's disease and chronic constipation. BMJ Open Gastroenterol 2016;3:e000118. [PMID: 27843572 DOI: 10.1136/bmjgast-2016-000118] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
157 Wan J, Zhou S, Mea HJ, Guo Y, Ku H, Urbina BM. Emerging Roles of Microfluidics in Brain Research: From Cerebral Fluids Manipulation to Brain-on-a-Chip and Neuroelectronic Devices Engineering. Chem Rev 2022. [PMID: 35080375 DOI: 10.1021/acs.chemrev.1c00480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Camilleri M. Gastrointestinal motility disorders in neurologic disease. J Clin Invest 2021;131:143771. [PMID: 33586685 DOI: 10.1172/JCI143771] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
159 Polychronis S, Nasios G, Dardiotis E, Messinis L, Pagano G. Pathophysiology and Symptomatology of Drooling in Parkinson’s Disease. Healthcare 2022;10:516. [DOI: 10.3390/healthcare10030516] [Reference Citation Analysis]
160 Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 2018;33:372-90. [PMID: 29508455 DOI: 10.1002/mds.27344] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 26.7] [Reference Citation Analysis]
161 Usama Ashhar M, Vyas P, Vohora D, Kumar Sahoo P, Nigam K, Dang S, Ali J, Baboota S. Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease. Int J Pharm 2022;618:121683. [PMID: 35314276 DOI: 10.1016/j.ijpharm.2022.121683] [Reference Citation Analysis]
162 Polychronis S, Dervenoulas G, Yousaf T, Niccolini F, Pagano G, Politis M. Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson's patients. PLoS One 2019;14:e0214352. [PMID: 31344030 DOI: 10.1371/journal.pone.0214352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
163 McQuade RM, Singleton LM, Wu H, Lee S, Constable R, Di Natale M, Ringuet MT, Berger JP, Kauhausen J, Parish CL, Finkelstein DI, Furness JB, Diwakarla S. The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson's disease. Sci Rep 2021;11:7934. [PMID: 33846426 DOI: 10.1038/s41598-021-86917-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Yang D, Zhao D, Ali Shah SZ, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Front Neurol 2019;10:1155. [PMID: 31781020 DOI: 10.3389/fneur.2019.01155] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
165 De Rui M, Inelmen EM, Trevisan C, Pigozzo S, Manzato E, Sergi G. Parkinson's disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia. Aging Clin Exp Res 2020;32:1211-8. [PMID: 31989535 DOI: 10.1007/s40520-020-01470-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
166 Rosario D, Boren J, Uhlen M, Proctor G, Aarsland D, Mardinoglu A, Shoaie S. Systems Biology Approaches to Understand the Host-Microbiome Interactions in Neurodegenerative Diseases. Front Neurosci 2020;14:716. [PMID: 32733199 DOI: 10.3389/fnins.2020.00716] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
167 Li K, Wang Z, Chen Y, Shen L, Li Z, Wu Y, Yuan C, Huang Y, Wu L, Bao C, Zhang W, Xu S, Wu H. Efficacy of electroacupuncture for the treatment of constipation in Parkinson's disease: study protocol for a multicentre randomised controlled trial. BMJ Open 2019;9:e029841. [PMID: 31780587 DOI: 10.1136/bmjopen-2019-029841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
168 Deidda G, Biazzo M. Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Front Neurosci 2021;15:753915. [PMID: 34712115 DOI: 10.3389/fnins.2021.753915] [Reference Citation Analysis]
169 Obata Y, Pachnis V. The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System. Gastroenterology. 2016;151:836-844. [PMID: 27521479 DOI: 10.1053/j.gastro.2016.07.044] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 15.8] [Reference Citation Analysis]
170 Yoon SY, Shin J, Heo SJ, Chang JS, Sunwoo MK, Kim YW. Irritable bowel syndrome and subsequent risk of Parkinson's disease: a nationwide population-based matched-cohort study. J Neurol 2021. [PMID: 34255181 DOI: 10.1007/s00415-021-10688-2] [Reference Citation Analysis]
171 Georgopoulos SD, Michopoulos S, Rokkas T, Apostolopoulos P, Giamarellos E, Kamberoglou D, Mentis A, Triantafyllou K. Hellenic consensus on Helicobacter pylori infection. Ann Gastroenterol 2020;33:105-24. [PMID: 32127732 DOI: 10.20524/aog.2020.0446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
172 Chen TJ, Feng Y, Liu T, Wu TT, Chen YJ, Li X, Li Q, Wu YC. Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease. Front Neurosci 2020;14:549037. [PMID: 33381005 DOI: 10.3389/fnins.2020.549037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
173 Lai F, Jiang R, Xie W, Liu X, Tang Y, Xiao H, Gao J, Jia Y, Bai Q. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease. Neurochem Res 2018;43:1986-99. [PMID: 30171422 DOI: 10.1007/s11064-018-2620-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
174 Guan X, Wang Y, Li Q, Wei M, Chen L, Cheng O. Analysis of the clinical features of early Parkinson's disease with comparatively integrated intestinal function. Neurol Sci 2018;39:1847-56. [PMID: 30019200 DOI: 10.1007/s10072-018-3502-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
175 Claus I, Suttrup J, Muhle P, Suntrup-Krueger S, Siemer ML, Lenze F, Dziewas R, Warnecke T. Subtle Esophageal Motility Alterations in Parkinsonian Syndromes: Synucleinopathies vs. Tauopathies. Mov Disord Clin Pract 2018;5:406-12. [PMID: 30363410 DOI: 10.1002/mdc3.12616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
176 Chen Y, Huang H, Ning P, Zhao Q, Wang H, Shen Q, Xu Y. Frequency and factors related to drooling in Chinese patients with multiple system atrophy: a cross-sectional study. Clin Auton Res 2019;29:595-601. [PMID: 30864043 DOI: 10.1007/s10286-019-00602-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
177 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
178 Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G. Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review). Mol Med Rep 2021;24:734. [PMID: 34414447 DOI: 10.3892/mmr.2021.12374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Nimmo JT, Smith H, Wang CY, Teeling JL, Nicoll JAR, Verma A, Dodart JC, Liu Z, Lin F, Carare RO. Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut. Acta Neuropathol 2022;143:55-73. [PMID: 34741635 DOI: 10.1007/s00401-021-02381-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
180 Padhi P, Worth C, Zenitsky G, Jin H, Sambamurti K, Anantharam V, Kanthasamy A, Kanthasamy AG. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders. Front Neurosci 2022;16:836605. [DOI: 10.3389/fnins.2022.836605] [Reference Citation Analysis]
181 Liu B, Fang F, Ye W, Wirdefeldt K. Appendectomy, Tonsillectomy and Parkinson's Disease Risk: A Swedish Register-Based Study. Front Neurol 2020;11:510. [PMID: 32595591 DOI: 10.3389/fneur.2020.00510] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
182 Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ, O'Brien JT. New evidence on the management of Lewy body dementia.Lancet Neurol. 2020;19:157-169. [PMID: 31519472 DOI: 10.1016/S1474-4422(19)30153-X] [Cited by in Crossref: 45] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
183 Skjærbæk C, Knudsen K, Horsager J, Borghammer P. Gastrointestinal Dysfunction in Parkinson's Disease. J Clin Med 2021;10:493. [PMID: 33572547 DOI: 10.3390/jcm10030493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
184 Rusch C, Beke M, Tucciarone L, Dixon K, Nieves C Jr, Mai V, Stiep T, Tholanikunnel T, Ramirez-Zamora A, Hess CW, Langkamp-Henken B. Effect of a Mediterranean diet intervention on gastrointestinal function in Parkinson's disease (the MEDI-PD study): study protocol for a randomised controlled trial. BMJ Open 2021;11:e053336. [PMID: 34551955 DOI: 10.1136/bmjopen-2021-053336] [Reference Citation Analysis]
185 Menozzi E, Macnaughtan J, Schapira AHV. The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med 2021;53:611-25. [PMID: 33860738 DOI: 10.1080/07853890.2021.1890330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
186 Zhang Y, He X, Qian Y, Xu S, Mo C, Yan Z, Yang X, Xiao Q. Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson's disease. NPJ Parkinsons Dis 2022;8:48. [PMID: 35449203 DOI: 10.1038/s41531-022-00312-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Schonhoff AM, Williams GP, Wallen ZD, Standaert DG, Harms AS. Innate and adaptive immune responses in Parkinson's disease. Prog Brain Res 2020;252:169-216. [PMID: 32247364 DOI: 10.1016/bs.pbr.2019.10.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
188 Iriondo-DeHond A, Uranga JA, Del Castillo MD, Abalo R. Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain-Gut Axis. Nutrients 2020;13:E88. [PMID: 33383958 DOI: 10.3390/nu13010088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
189 Khodakarami H, Ricciardi L, Contarino MF, Pahwa R, Lyons KE, Geraedts VJ, Morgante F, Leake A, Paviour D, De Angelis A, Horne M. Prediction of the Levodopa Challenge Test in Parkinson's Disease Using Data from a Wrist-Worn Sensor. Sensors (Basel) 2019;19:E5153. [PMID: 31775289 DOI: 10.3390/s19235153] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
190 Giuffrè M, Moretti R, Campisciano G, da Silveira ABM, Monda VM, Comar M, Di Bella S, Antonello RM, Luzzati R, Crocè LS. You Talking to Me? Says the Enteric Nervous System (ENS) to the Microbe. How Intestinal Microbes Interact with the ENS. J Clin Med 2020;9:E3705. [PMID: 33218203 DOI: 10.3390/jcm9113705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
191 Schmidt C, Planchette AL, Nguyen D, Giardina G, Neuenschwander Y, Franco MD, Mylonas A, Descloux AC, Pomarico E, Radenovic A, Extermann J. High resolution optical projection tomography platform for multispectral imaging of the mouse gut. Biomed Opt Express 2021;12:3619-29. [PMID: 34221683 DOI: 10.1364/BOE.423284] [Reference Citation Analysis]
192 Song B, Feldmann JW, Cao S, Feitosa M, Kong Y, Kim W, Schweitzer A, Leblanc P, Schweitzer JS, Kim K. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105777] [Reference Citation Analysis]
193 Maria-Ferreira D, de Oliveira NMT, da Silva LCM, Fernandes ES. Evidence of a Role for the TRPC Subfamily in Mediating Oxidative Stress in Parkinson's Disease. Front Physiol 2020;11:332. [PMID: 32457638 DOI: 10.3389/fphys.2020.00332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
194 Freitas ME, Alqaraawi A, Lang AE, Liu LWC. Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism. Mov Disord Clin Pract 2018;5:218-20. [PMID: 30746404 DOI: 10.1002/mdc3.12577] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
195 Kempster PA, Perju-Dumbrava L. The Thermodynamic Consequences of Parkinson's Disease. Front Neurol 2021;12:685314. [PMID: 34512508 DOI: 10.3389/fneur.2021.685314] [Reference Citation Analysis]
196 Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol. 2018;6:133-148. [PMID: 30023410 DOI: 10.1016/j.jcmgh.2018.04.003] [Cited by in Crossref: 283] [Cited by in F6Publishing: 253] [Article Influence: 70.8] [Reference Citation Analysis]
197 Giladi N, Gurevich T, Djaldetti R, Adar L, Case R, Leibman-Barak S, Sasson N, Caraco Y. ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study. Parkinsonism Relat Disord 2021;91:139-45. [PMID: 34619438 DOI: 10.1016/j.parkreldis.2021.09.024] [Reference Citation Analysis]
198 Bicknell B, Liebert A, McLachlan CS, Kiat H. Microbiome Changes in Humans with Parkinson's Disease after Photobiomodulation Therapy: A Retrospective Study. J Pers Med 2022;12:49. [PMID: 35055364 DOI: 10.3390/jpm12010049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
199 Rascol O, Negre-pages L, Damier P, Delval A, Derkinderen P, Destée A, Fabbri M, Meissner WG, Rachdi A, Tison F, Perez-lloret S; for the COPARK Study Group. Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort. J Neural Transm 2020;127:1607-17. [DOI: 10.1007/s00702-020-02249-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
200 Shah P, Sagar PR, Alhumaidi N, Bollampally VC, Malik BH. Parkinson's Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis? Cureus 2020;12:e9933. [PMID: 32968594 DOI: 10.7759/cureus.9933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
201 Sun X, Xue L, Wang Z, Xie A. Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism. Front Neurosci 2022;16:878239. [PMID: 35873830 DOI: 10.3389/fnins.2022.878239] [Reference Citation Analysis]
202 Aldaz T, Nigro P, Sánchez-Gómez A, Painous C, Planellas L, Santacruz P, Cámara A, Compta Y, Valldeoriola F, Martí MJ, Muñoz E. Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease. J Neurol 2019;266:1340-50. [PMID: 30834978 DOI: 10.1007/s00415-019-09263-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
203 Labeit B, Claus I, Muhle P, Suntrup-Krueger S, Dziewas R, Warnecke T. Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson's Disease. Parkinsons Dis 2020;2020:4260501. [PMID: 32257098 DOI: 10.1155/2020/4260501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
204 Sambra V, Echeverria F, Valenzuela A, Chouinard-Watkins R, Valenzuela R. Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle. Nutrients 2021;13:986. [PMID: 33803760 DOI: 10.3390/nu13030986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
205 Travagli RA, Anselmi L. Vagal neurocircuitry and its influence on gastric motility. Nat Rev Gastroenterol Hepatol. 2016;13:389-401. [PMID: 27251213 DOI: 10.1038/nrgastro.2016.76] [Cited by in Crossref: 141] [Cited by in F6Publishing: 113] [Article Influence: 23.5] [Reference Citation Analysis]
206 Memic F, Knoflach V, Morarach K, Sadler R, Laranjeira C, Hjerling-Leffler J, Sundström E, Pachnis V, Marklund U. Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System. Gastroenterology 2018;154:624-36. [PMID: 29031500 DOI: 10.1053/j.gastro.2017.10.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
207 Barbut D, Stolzenberg E, Zasloff M. Gastrointestinal Immunity and Alpha-Synuclein. J Parkinsons Dis 2019;9:S313-22. [PMID: 31594249 DOI: 10.3233/JPD-191702] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
208 Tuk B. Overstimulation of the inhibitory nervous system plays a role in the pathogenesis of neuromuscular and neurological diseases: a novel hypothesis. F1000Res 2016;5:1435. [PMID: 27547379 DOI: 10.12688/f1000research.8774.2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
209 Wang XX, Feng Y, Li X, Zhu XY, Truong D, Ondo WG, Wu YC. Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor. Front Neurol 2020;11:874. [PMID: 32982913 DOI: 10.3389/fneur.2020.00874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
210 Baba Y, Futamura A, Kinno R, Nomoto S, Takahashi S, Yasumoto T, Osakabe Y, Shoji D, Nabeshima Y. The relationship between the distinct ratios of benserazide and carbidopa to levodopa and motor complications in Parkinson's disease: A retrospective cohort study. Journal of the Neurological Sciences 2022. [DOI: 10.1016/j.jns.2022.120263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Ibrahim A, Ali RAR, Manaf MRA, Ahmad N, Tajurruddin FW, Qin WZ, Desa SHM, Ibrahim NM. Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial. PLoS One 2020;15:e0244680. [PMID: 33382780 DOI: 10.1371/journal.pone.0244680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
212 Li L, Lu J, Sun Y, Jin X. Acupuncture protects from 6-OHDA-induced neuronal damage by balancing the ratio of DMT1/Fpn1. Saudi J Biol Sci 2019;26:1948-55. [PMID: 31889778 DOI: 10.1016/j.sjbs.2019.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
213 Su Y, Liu N, Zhang Z, Hao L, Ma J, Yuan Y, Shi M, Liu J, Zhao Z, Zhang Z, Holscher C. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175029] [Reference Citation Analysis]
214 Mahurkar-Joshi S, Rankin CR, Videlock EJ, Soroosh A, Verma A, Khandadash A, Iliopoulos D, Pothoulakis C, Mayer EA, Chang L. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling. Gastroenterology 2021;160:2409-2422.e19. [PMID: 33617890 DOI: 10.1053/j.gastro.2021.02.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
215 Mehta SH, Adler CH. Advances in Biomarker Research in Parkinson's Disease. Curr Neurol Neurosci Rep 2016;16:7. [PMID: 26711276 DOI: 10.1007/s11910-015-0607-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
216 Kurnik-Łucka M, Pasieka P, Łączak P, Wojnarski M, Jurczyk M, Gil K. Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review. Int J Mol Sci 2021;22:12932. [PMID: 34884737 DOI: 10.3390/ijms222312932] [Reference Citation Analysis]
217 Waclawiková B, Bullock A, Schwalbe M, Aranzamendi C, Nelemans SA, van Dijk G, El Aidy S. Gut bacteria-derived 5-hydroxyindole is a potent stimulant of intestinal motility via its action on L-type calcium channels. PLoS Biol 2021;19:e3001070. [PMID: 33481771 DOI: 10.1371/journal.pbio.3001070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
218 Arena G, Sharma K, Agyeah G, Krüger R, Grünewald A, Fitzgerald JC. Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop. Curr Neurol Neurosci Rep 2022. [PMID: 35674870 DOI: 10.1007/s11910-022-01207-5] [Reference Citation Analysis]
219 Beckers M, Bloem BR, Verbeek MM. Mechanisms of peripheral levodopa resistance in Parkinson's disease. NPJ Parkinsons Dis 2022;8:56. [PMID: 35546556 DOI: 10.1038/s41531-022-00321-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Sun BH, Wang T, Li NY, Wu Q, Qiao J. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease. World J Gastrointest Pharmacol Ther 2021; 12(1): 21-31 [PMID: 33564494 DOI: 10.4292/wjgpt.v12.i1.21] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, Svenningsson P, Chen H, Wirdefeldt K. Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study. Neurology 2017;88:1996-2002. [PMID: 28446653 DOI: 10.1212/WNL.0000000000003961] [Cited by in Crossref: 176] [Cited by in F6Publishing: 100] [Article Influence: 35.2] [Reference Citation Analysis]
222 Zhu F, Li C, Chu F, Tian X, Zhu J. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease. Front Aging Neurosci 2020;12:544235. [PMID: 33132894 DOI: 10.3389/fnagi.2020.544235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
223 van Kessel SP, El Aidy S. Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease. Front Neurol 2019;10:1087. [PMID: 31681153 DOI: 10.3389/fneur.2019.01087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
224 Kalampokini S, Becker A, Fassbender K, Lyros E, Unger MM. Nonpharmacological Modulation of Chronic Inflammation in Parkinson's Disease: Role of Diet Interventions. Parkinsons Dis 2019;2019:7535472. [PMID: 31534664 DOI: 10.1155/2019/7535472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
225 Simons JA, Vaillant M, Hipp G, Pavelka L, Stute L, Pauly C, Krüger R. Multilingual Validation of the First French Version of Munich Dysphagia Test-Parkinson's Disease (MDT-PD) in the Luxembourg Parkinson's Study. Front Neurol 2019;10:1180. [PMID: 31781022 DOI: 10.3389/fneur.2019.01180] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
226 Niccolini F, Wilson H, Giordano B, Diamantopoulos K, Pagano G, Chaudhuri KR, Politis M. Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson's disease. BMC Neurosci 2019;20:55. [PMID: 31640554 DOI: 10.1186/s12868-019-0537-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
227 Lubomski M, Davis RL, Sue CM. Gastrointestinal dysfunction in Parkinson's disease. J Neurol. 2020;267:1377-1388. [PMID: 31989280 DOI: 10.1007/s00415-020-09723-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
228 Manfready RA, Forsyth CB, Voigt RM, Hall DA, Goetz CG, Keshavarzian A. Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1. Curr Neurol Neurosci Rep 2022. [PMID: 35633466 DOI: 10.1007/s11910-022-01196-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Xu J, Wang L, Chen X, Le W. New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease. Front Aging Neurosci 2022;14:917499. [DOI: 10.3389/fnagi.2022.917499] [Reference Citation Analysis]
230 Sauerbier A, Qamar MA, Rajah T, Chaudhuri KR. New concepts in the pathogenesis and presentation of Parkinson's disease. Clin Med (Lond) 2016;16:365-70. [PMID: 27481383 DOI: 10.7861/clinmedicine.16-4-365] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
231 Ravn AH, Thyssen JP, Egeberg A. Skin disorders in Parkinson's disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol 2017;10:87-92. [PMID: 28331352 DOI: 10.2147/CCID.S130319] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
232 Sharpe G, Macerollo A, Fabbri M, Tripoliti E. Non-pharmacological Treatment Challenges in Early Parkinson's Disease for Axial and Cognitive Symptoms: A Mini Review. Front Neurol 2020;11:576569. [PMID: 33101185 DOI: 10.3389/fneur.2020.576569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]